# Vincristine Pharmacokinetics in Infants

> **NCT05359237** · — · ACTIVE_NOT_RECRUITING · sponsor: **Children's Oncology Group** · enrollment: 83 (estimated)

## Conditions studied

- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **DRUG:** Vincristine

## Key facts

- **NCT ID:** NCT05359237
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-16
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 83 (ESTIMATED)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05359237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05359237, "Vincristine Pharmacokinetics in Infants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05359237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*